Estonia - estoniană - Ravimiamet

gedeon richter plc. - desogestreel+etünüülöstradiool - õhukese polümeerikattega tablett - 0,15mg+0,02mg 21tk

Estonia - estoniană - Ravimiamet

sia elvim - dutasteriid - pehmekapsel - 0,5mg 30tk

Estonia - estoniană - Ravimiamet

sandoz pharmaceuticals d.d. - tamsulosiin+dutasteriid - kõvakapsel - 0,4mg+0,5mg 90tk; 0,4mg+0,5mg 7tk

Estonia - estoniană - Ravimiamet

lex ano uab - desogestreel+etünüülöstradiool - õhukese polümeerikattega tablett - 0,15mg+0,02mg 21tk; 0,15mg+0,02mg 63tk

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

argenx - efgartigimod alfa - myasthenia gravis - immunosupressandid - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Estonia - estoniană - Ravimiamet

ideal trade links uab - desogestreel+etünüülöstradiool - õhukese polümeerikattega tablett - 0,15mg+0,02mg 21tk; 0,15mg+0,02mg 63tk

Estonia - estoniană - Ravimiamet

first pharma oÜ - dutasteriid - pehmekapsel - 0,5mg 60tk; 0,5mg 50tk

Estonia - estoniană - Ravimiamet

ideal trade links uab - tamsulosiin+dutasteriid - kõvakapsel - 0,4mg+0,5mg 180tk; 0,4mg+0,5mg 90tk

Estonia - estoniană - Ravimiamet

ideal trade links uab - dutasteriid - pehmekapsel - 0,5mg 90tk; 0,5mg 30tk; 0,5mg 10tk; 0,5mg 60tk

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

sanofi winthrop industrie - liksisenadiidi - suhkurtõbi, tüüp 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.